Malinowska Katarzyna, Morawiec-Sztandera Alina, Majsterek Ireneusz, Kaczmarczyk Dariusz
Department of Chemistry and Clinical Biochemistry Medical University of Lodz, Poland.
Department of Head and Neck Neoplasms Surgery Medical University of Lodz, Poland.
Otolaryngol Pol. 2016 Nov 20;70(6):20-25. doi: 10.5604/01.3001.0009.3735.
Head and neck squamous cell carcinoma (HNSCC) accounts for about 6% of all malignant cancers. In the epidemiology of oral cavity neoplasm, important risk factors include: tobacco smoking, alcohol abuse, bad oral hygiene, papilloma virus infection, riboflavin and iron deficiency.
The objective of the investigation was a synthesis of Cu(II) complex and the evaluation of antioxidative enzymatic barrier in red blood cells of patients with head and neck tumor as well as in the control group.
For the investigation conduction, a consent of Bioethics Committee number RNN/142/09/KB was obtained. Blood for the examination was obtained from the patients of the Dapartment of Head and Neck Neoplasms Surgery Medical University of Łódź. The experiment was conducted on the group of 40 patients with HNSCC and 40 healthy people, using spectrophotometric method, glutathione peroxidase was marked.
The investigation was conducted on the hemolysate obtained from the patients that were divided into two groups - a study group (1 and 2), which consisted of patients diagnosed with head and neck cancer and a control group (1 and 2) - healthy people. A significant statistical result for GPX occurred in control-1 and study-1 group with complex compound Cu(II) (p<0,001).
Presented research prove, that complex compound Cis-dichlorobis(N1-hydroxymethyl-3methylpyrazole-κN2)copper (II) has an impact on the activity of the antioxidative GPX enzyme.
头颈部鳞状细胞癌(HNSCC)约占所有恶性肿瘤的6%。在口腔肿瘤流行病学中,重要的风险因素包括:吸烟、酗酒、口腔卫生不良、乳头瘤病毒感染、核黄素和铁缺乏。
本研究的目的是合成铜(II)配合物,并评估头颈部肿瘤患者及对照组红细胞中的抗氧化酶屏障。
为进行本研究,获得了生物伦理委员会编号为RNN/142/09/KB的批准。检测血液取自罗兹医科大学头颈肿瘤外科的患者。实验对40名头颈部鳞状细胞癌患者和40名健康人进行,采用分光光度法标记谷胱甘肽过氧化物酶。
研究在从患者获得的溶血产物上进行,患者分为两组——研究组(1和2),由诊断为头颈部癌的患者组成,以及对照组(1和2)——健康人。在对照组1和研究组1中,使用复合铜(II)时谷胱甘肽过氧化物酶出现了显著的统计学结果(p<0.001)。
目前的研究证明,复合化合物顺二氯双(N1-羟甲基-3-甲基吡唑-κN2)铜(II)对抗氧化谷胱甘肽过氧化物酶的活性有影响。